Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015)
- Dechuang Jiao
- Jiujun Zhu
- Xianfu Sun
- Zhenduo Lu
- Jianghua Qiao
- Xiuchun Chen
- Chengzheng Wang
- Min Yan
- Chongjian Zhang
- Lianfang Li
- Jianfei Wang
- Min Jin
- Yijia Wu
- Zhenzhen Liu
2026-08-31